ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · IEX Real-Time Price · USD
6.15
-0.46 (-6.96%)
At close: Jul 19, 2024, 4:00 PM
6.22
+0.07 (1.14%)
Pre-market: Jul 22, 2024, 7:18 AM EDT

ALX Oncology Holdings Statistics

Total Valuation

ALXO has a market cap or net worth of $320.42 million. The enterprise value is $172.68 million.

Market Cap 320.42M
Enterprise Value 172.68M

Important Dates

The next estimated earnings date is Thursday, August 8, 2024, after market close.

Earnings Date Aug 8, 2024
Ex-Dividend Date n/a

Share Statistics

ALXO has 52.10 million shares outstanding. The number of shares has increased by 22.66% in one year.

Shares Outstanding 52.10M
Shares Change (YoY) +22.66%
Shares Change (QoQ) +2.16%
Owned by Insiders (%) 2.03%
Owned by Institutions (%) 93.98%
Float 21.35M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.95
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.21, with a Debt / Equity ratio of 0.06.

Current Ratio 5.21
Quick Ratio n/a
Debt / Equity 0.06
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -102.55

Financial Efficiency

Return on equity (ROE) is -90.40% and return on invested capital (ROIC) is -101.12%.

Return on Equity (ROE) -90.40%
Return on Assets (ROA) -72.20%
Return on Capital (ROIC) -101.12%
Revenue Per Employee n/a
Profits Per Employee -$2.31M
Employee Count 72
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -13.56% in the last 52 weeks. The beta is 1.06, so ALXO's price volatility has been similar to the market average.

Beta (5Y) 1.06
52-Week Price Change -13.56%
50-Day Moving Average 9.56
200-Day Moving Average 11.59
Relative Strength Index (RSI) 38.79
Average Volume (20 Days) 1,131,802

Short Selling Information

The latest short interest is 5.51 million, so 10.58% of the outstanding shares have been sold short.

Short Interest 5.51M
Short Previous Month 4.24M
Short % of Shares Out 10.58%
Short % of Float 25.82%
Short Ratio (days to cover) 4.75

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -175.84M
Pretax Income -166.20M
Net Income -166.20M
EBITDA -163.76M
EBIT -164.60M
Earnings Per Share (EPS) -$3.71
Full Income Statement

Balance Sheet

The company has $157.44 million in cash and $9.70 million in debt, giving a net cash position of $147.73 million or $2.84 per share.

Cash & Cash Equivalents 157.44M
Total Debt 9.70M
Net Cash 147.73M
Net Cash Per Share $2.84
Equity (Book Value) 164.20M
Book Value Per Share 3.15
Working Capital 135.64M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$140.47 million and capital expenditures -$732,000, giving a free cash flow of -$141.20 million.

Operating Cash Flow -140.47M
Capital Expenditures -732,000
Free Cash Flow -141.20M
FCF Per Share -$2.82
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ALXO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -22.66%
Shareholder Yield -22.66%
Earnings Yield -51.87%
FCF Yield -44.07%

Analyst Forecast

The average price target for ALXO is $20.50, which is 233.33% higher than the current price. The consensus rating is "Strong Buy".

Price Target $20.50
Price Target Difference 233.33%
Analyst Consensus Strong Buy
Analyst Count 7
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1